Schedule I

For almost 50 years, hemp has been considered a Schedule I substance alongside more potent strains of marijuana. Congress is finally set to change that.
There is a major political debate currently happening in many parts of this country, but the astonishing thing is that most politicians -- especially those on the national stage -- seem to want to pretend the debate doesn't even exist.
A new petition responds to news that the feds are making the herb a Schedule I controlled substance.
A new DEA push against kratom shows drug warriors haven't learned from past failures.
But rescheduling marijuana would not have allowed doctors to prescribe marijuana nationwide. Coca leaves, from which cocaine is derived, are listed in Schedule II, but physicians cannot prescribe coca leaves -- and pharmacies cannot sell these leaves -- because no one has moved coca leaves through the FDA approval process to make them available by prescription.
This column has always loved a good rant. Most of the time, we provide our own rant at the end of the column, on a subject too big to be contained in talking points.
Is there any hope for legalizing whole plant cannabis for medical use nationwide?
The end of the federal government's War On Weed is approaching fast. No matter how the details work out, that much seems pretty clear at this point.
There was some good news and some bad news on marijuana this week, which got us thinking about how the subject of federal marijuana policy relates to the presidential nomination race.
Hillary Clinton just had the best week of her campaign yet. Not only did she shine at the Benghazi hearing yesterday, three of her Democratic opponents dropped out of the presidential nomination race.
The concept that the federal "War On Weed" needs to end is now about as mainstream as it gets, and after the people have led so admirably on the issue in the past decade, the politicians are finally deciding it is safe to follow this trend.
In normal years, this would be the official kickoff to the political Silly Season. This year, however, is not normal, as instead we're right at the kickoff of Presidential Debate Season, and the votes are already in -- the silly subject we're all going to obsess over this year is named Donald Trump.
Count me among the satisfied that Leonhart will be leaving her government job soon. With her departure, President Obama now has the opportunity to name someone to the job who can clearly see the future of drug policy reform.
On one issue, though, there is a sizeable (and growing) bloc of voters who are not only cross-partisan but also so committed they could be called "single-issue voters." I'm speaking of the marijuana vote. And it could be up for grabs next year.
Seen as a whole, the current federal attitude towards marijuana can truly be described as "doublethink." There are so many contradictions in the government's attitude that they are indeed hard to accurately count.
The news that Attorney General Eric Holder would be stepping down sent a shockwave through Washington. On the whole, was his term worth praising or condemning? We have to say that "both" is the only real answer to that question.
According to the Controlled Substances Act, Eric Holder himself can reclassify anything on the list, with no more authority necessary than his own signature. Perhaps if Congress refuses to act, Holder (or Obama) will make this change on his own. That, more than a Times editorial, might more accurately be called marijuana's tipping point.